- Global Pharma News & Resources

Isohelix and Precision Genetics Partner to Expand COVID-19 Testing Using Saliva Collection Technology

The Isohelix GeneFiX™ Saliva RNA Collection Device facilitates simplified, reliable COVID-19 testing at Precision Genetics’ laboratory under the U.S. FDA EUA

HARRIETSHAM, UK – (November 12, 2020) – Life Science Newswire – Isohelix, a specialist provider of DNA and RNA sampling and purification products, announced that its state-of-the-art GeneFiX™ Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics, a leading healthcare technology company and high capacity molecular testing laboratory. The high-performance, easy-to-use device marks the latest addition to Precision Genetics’ extensive portfolio of validated COVID-19 testing options submitted under the U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA).   "We are proud that our GeneFix Saliva RNA Collection Device is being used as a valuable, dependable method at the Precision Genetics testing laboratory, where a wide variety of SARS-CoV-2 assays are being implemented to contribute to the global fight against COVID-19," said Tom Hole, CEO of Isohelix. "Precision Genetics reviewed various saliva collection kits and chose the GeneFix Saliva RNA Collection Device for its superior simplicity and reliable performance."

The addition of saliva collection to Precision Genetics’ testing capabilities comes at a time when alternative collection methods for COVID-19 testing are increasingly important. Saliva collection allows a person to expel their saliva into a tube, making it far less invasive than the nasopharyngeal (NP) collection method. In addition, saliva collection offers ease and convenience for more populations and demographics.

"Saliva collection not only reduces exposure to the SARS-CoV-2 virus for healthcare professionals supervising the collection process, but as importantly offers a less invasive and comfortable alternative for groups that might require this option," explained Nate Wilbourne, CEO of Precision Genetics.

The GeneFix Saliva DNA/RNA Collection Devices maximize the yield and quality of the DNA and RNA collected, whilst offering long term stabilization at room temperature. The devices are easy to use and integrate seamlessly into most manual and HT processing kits, with 1 and 2d bar coding, automation friendly features all specified for leak proof mailing.

More information about the GeneFix Saliva DNA/RNA Collection Devices is available here.

About Isohelix
Isohelix is a UK manufacturing company with an international supply footprint, focused on expanding a range of DNA and RNA products for collection, stabilization and purification of various tissues sources for research, diagnostic and medical applications under the GeneFix, BuccalfiX and StoolFix brands. For more information, please visit

About Precision Genetics
From the beginning of the COVID-19 pandemic, Precision Genetics has been working diligently with healthcare organizations, employers, and academic institutions to help create a safe environment for not only our local communities, but nationwide. Precision Genetics prides itself on our ability to offer a range of Covid-19 services, with quick turnaround times of less than 24 hours. For more information on how your organization can benefit from our quick and reliable saliva testing capabilities, please visit, send inquiries to, or call our team at 877.843.6544 (ext 4).
Isohelix and Precision Genetics Partner to Expand COVID-19 Testing Using Saliva Collection Technology

Editor Details

Last Updated: 12-Nov-2020